Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: al who wrote (10026)	6/25/1998 8:24:00 AM
From: sailor	Read Replies (1) \| Respond to of 23519

Here she is: <<MOUNTAIN VIEW, Calif.--(BW HealthWire)--June 25, 1998--VIVUS, Inc. (NASDAQ:VVUS - news) today announced that the United States Food and Drug Administration has cleared the Company's supplemental application for commercial production of MUSE(R) (alprostadil) in its new 90,000 square foot plant located in Lakewood, New Jersey. ''VIVUS is proud of the excellent efforts on the part of our manufacturing and regulatory teams. Concept, construction and approval of our facility were completed within 18 months of project initiation,'' said Leland Wilson, President and Chief Executive Officer. ''This regulatory milestone, along with the March 1998 approval of our manufacturing facility by the Medicines Control Agency (MCA) of the United Kingdom, will allow VIVUS to produce MUSE for distribution around the globe.'' >> See you guys a a couple of weeks Sailor PS see some of you sooner ;o)